KR860003227A - 9-아미노-1,2,3,4,-테트라하이드로아크리딘-1-올의 제조방법 - Google Patents

9-아미노-1,2,3,4,-테트라하이드로아크리딘-1-올의 제조방법 Download PDF

Info

Publication number
KR860003227A
KR860003227A KR1019850007899A KR850007899A KR860003227A KR 860003227 A KR860003227 A KR 860003227A KR 1019850007899 A KR1019850007899 A KR 1019850007899A KR 850007899 A KR850007899 A KR 850007899A KR 860003227 A KR860003227 A KR 860003227A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
hydrogen
optionally
Prior art date
Application number
KR1019850007899A
Other languages
English (en)
Other versions
KR900007624B1 (ko
Inventor
엠. 슈트스케 그레고리 (외 1)
Original Assignee
마크 에드워드 로가르트
훽스트-럿셀 파마슈티컬스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/664,731 external-priority patent/US4631286A/en
Priority claimed from US06/781,155 external-priority patent/US4695573A/en
Application filed by 마크 에드워드 로가르트, 훽스트-럿셀 파마슈티컬스 인코포레이티드 filed Critical 마크 에드워드 로가르트
Publication of KR860003227A publication Critical patent/KR860003227A/ko
Application granted granted Critical
Publication of KR900007624B1 publication Critical patent/KR900007624B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C07D219/12—Amino-alkylamino radicals attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

내용 없음

Description

-아미노-1,2,3,4,-테트라하이드로아크리딘-1-올의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 하기 일반식(Ⅱ)의 화합물을 금속할라이드의 존재하에 폐환시켜 하기 일반식(Ⅳ)의 화합물을 제조한후; X가 하이드록시, 이미노, C1-C6알킬아미노 또는 NHCOR2가 아닌 하기 일반식(Ⅳ)의 화합물을 임의로 일반식 R1W의 화합물(여기서, R1은 수소가 아니며 W는 Cl,Br,I 또는 라디칼 OSO3CH3이다)과 반응시켜 하기 일반식(Ⅴ)의 화합물(여기서, R1은 수소가 아니며 X는 하이드록시, 아미노, C1-C6-알킬아미노 또는 그룹 NHCOR2가 아니다)을 제조하고; 이 일반식(Ⅴ)의 화합물을 임의로 일반식 RW의 화합물(여기서 R은 수소가 아니며, W는 상기에서 정의한 바와 같다)과 반응시켜 하기 일반식(Ⅵ)의 화합물을 제조하고; X가 C1-C6알콕시인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 임의로 제거반응시켜 X가 하이드록시인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조하고; X가 수소인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 임의로 질환시켜 X가 니트로그룹인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조하고; X가 니트로그룹인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 임의로 수소첨가반응시켜 X가 아미노그룹인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조하고; X가 아미노그룹인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 임의로 아실화시켜 X가 -NHCOR2라디칼인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조하고; X가 -NHCOR2라디칼인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 임의로 C1-C6-알킬요오드화물이나 브롬화물과 반응시켜 X가 그룹인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조한 후, 이 화합물을 가수분해시켜 X가 C1-C6-알킬아미노인 일반식(Ⅴ)의 화합물 또는 일반식(Ⅵ)의 화합물을 제조하고; R,R1및 X가 하기에서 정의하는 바와 같은 일반식(Ⅵ)의 화합물을 임의로 하기 일반식(XV)의 화합물과 환원반응시켜 하기 일반식(XVI)의 화합물을 제조한 후, 이 중간 생성물을 더 분합시켜 하기 일반식(XIV)의 화합물을 제조하고; 하기 일반식(XI) 및 (XⅢ)의 화합물(여기서, X는 -NCOR2또는 -NO2은 아니다)을 임의로 탈수시켜 하기 일반식(XVⅡ)의 화합물을 제조하고; 하기 일반식(XIV)의 화합물(여기서, X는 -NO2또는 -NHCOR2는 아니다)을 임의로 (i-부틸)2AlH 또는 R5Li(여기서 R5는 C1-C6알킬이다)와 반응시켜 하기 일반식(XVⅢ)의 화합물을 제조함을 특징으로 하는 하기 일반식(Ⅰ)의 화합물, 및 이의 광학대장체 및 제약학상 허용되는 산 부가염을 제조하는 방법.
    상기 일반식에서, n은 1,2 또는 3이고; X는 수소, C1-C6-알킬,C1-C6-알콕시, 할로겐, 하이드록시, 니트로, 트리플루오로메틸, NHCOR2(여기서, R2는 C1-C6-알킬이다) 또는 NR3R4(여기서, R3및 R4는 각각 수소 또는 C1-C6-알킬이다)이고; R은 수소 또는 C1-C6-알킬이고; R1은 수소, C1-C6-알킬, 디-C1-C6-알킬아미노-C1-C6-알킬, 아릴-C1-C6-알킬, 디아릴-C1-C6-알킬, 푸릴-C1-C6, 알킬, 티에닐-C1-C6-알킬, 산소-결합된 아릴-C1-C6-알킬, 산소-결합된 디아릴-C1-C6-알릴, 산소-결합된 푸릴-C1-C6-알킬 또는 산소-결합된 티에닐-C1-C6-알킬이고; Y는 C＝O 또는 CR5OH(여기서 R5는 수소 또는 C1-C6-알킬이다)이고; Z는 CH2또는 C＝CR6R7(여기서, R6및 R7은 각각 수소 또는 C1-C6-알킬이다)이거나; Y 및 Z가 함께 CR5＝CH(여기서 CR5및 CH는 각각 Y 및 Z에 상응한다)이다.
  2. 제1항에 있어서, n이 2임을 특징으로 하는 방법.
  3. 제2항에 있어서, R이 수소이고, R1이 수소, C1-C6-알킬, C1-C6-알콕시, 아릴-C1-C6-알킬 또는 디-아릴-C1-C6-알킬임을 특징으로 하는 방법.
  4. 제3항에 있어서, Z가 CH2이고 Y는 -C＝O 또는 CH2OH이거나, Y 및 Z가 함께 -CH＝CH- 라디칼을 형성함을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850007899A 1984-10-25 1985-10-25 9-아미노-1,2,3,4-테트라하이드로아크리딘-1-올 및 이의 제조방법 KR900007624B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US06/664,731 US4631286A (en) 1984-10-25 1984-10-25 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US644,731 1984-10-25
US664731 1984-10-25
US781155 1985-10-01
US06/781,155 US4695573A (en) 1984-10-25 1985-10-01 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US781,155 1985-10-01

Publications (2)

Publication Number Publication Date
KR860003227A true KR860003227A (ko) 1986-05-21
KR900007624B1 KR900007624B1 (ko) 1990-10-17

Family

ID=27099040

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007899A KR900007624B1 (ko) 1984-10-25 1985-10-25 9-아미노-1,2,3,4-테트라하이드로아크리딘-1-올 및 이의 제조방법

Country Status (20)

Country Link
US (1) US4839364A (ko)
EP (1) EP0179383B1 (ko)
JP (1) JPH01125362A (ko)
KR (1) KR900007624B1 (ko)
AR (1) AR247394A1 (ko)
AT (1) ATE63903T1 (ko)
AU (2) AU589141B2 (ko)
CA (1) CA1292744C (ko)
DE (1) DE3582995D1 (ko)
DK (2) DK167250B1 (ko)
ES (3) ES8701165A1 (ko)
FI (1) FI86421C (ko)
GR (1) GR852555B (ko)
HU (1) HU196183B (ko)
IE (1) IE58696B1 (ko)
IL (3) IL90300A (ko)
NO (1) NO172847C (ko)
NZ (2) NZ213932A (ko)
PH (1) PH22614A (ko)
PT (1) PT81362B (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
GB8610980D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
US4753950A (en) * 1986-11-24 1988-06-28 Hoechst-Roussel Pharmaceuticals, Inc. Fused heterocyclic tetrahydroaminoquinolinols and related compounds
US4897400A (en) * 1987-02-13 1990-01-30 Hoeschst-Roussel Pharmaceuticals, Inc. 9-amino-1,4-ethano-1,2,3,4-tetrahydroacridine and related compounds useful for incresing the cholinergic function in a mammal
FI91401C (fi) * 1987-03-17 1994-06-27 Hoechst Roussel Pharma Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
US4762841A (en) * 1987-03-30 1988-08-09 Hoechst-Roussel Pharmaceuticals Inc. Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes)
ATE92046T1 (de) * 1987-04-20 1993-08-15 Hoechst Roussel Pharma 9-hydroxyamino-tetrahydroacridine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
US6075144A (en) 1987-04-20 2000-06-13 Hoechst Marion Roussel, Inc. 9-hydroxyamino tetrahydroacridine and related compounds
US4843079A (en) * 1987-04-23 1989-06-27 Hoechst-Roussel Pharmaceuticals, Inc. Fused heteroalkylene quinolinamines
US4970316A (en) * 1987-05-07 1990-11-13 American Home Products Corporation Pyrano-, thiopyrano- and cyclohexylquinolines as inhibitors of interleukin 1
EP0306826A1 (en) * 1987-09-08 1989-03-15 Hoechst-Roussel Pharmaceuticals Incorporated N-(substituted alkylidene)fused bicycloalkylidene and hetero-alkylidene quinolinamines, a process for their preparation and their use as medicaments
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US5037833A (en) * 1988-07-25 1991-08-06 Hoechst-Roussel Pharmaceuticals Inc. N-[substituted alkylidene]fused-bicycloalkylidene quinolinamines useful for enhancing the cholinergic function in a mammal
US4800203A (en) * 1987-09-24 1989-01-24 Hoechst-Roussel Pharmaceuticals, Inc. Pyrrolo(1,2-b)cinnolines
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
ATE89553T1 (de) * 1988-11-16 1993-06-15 Hoechst Roussel Pharma Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel.
US4927820A (en) * 1988-11-25 1990-05-22 Hoechst Roussel Pharmaceuticals Inc. Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
RU2024509C1 (ru) * 1991-05-07 1994-12-15 Всероссийский научный центр по безопасности биологически активных веществ Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease
US5434165A (en) * 1991-11-18 1995-07-18 Sanawa Kagaku Kenkyusho Company, Ltd. Nootropic agents, compositions of, and method of use thereof
JP2873898B2 (ja) * 1992-04-13 1999-03-24 富山化学工業株式会社 ベンゾ［ｂ］チオフェン−５−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法
US5247091A (en) * 1992-07-30 1993-09-21 Hoechst Celanese Corporation Preparation of enamines in aqueous media
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
WO1995003052A1 (en) * 1993-07-22 1995-02-02 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
KR100381716B1 (ko) * 2000-10-09 2003-04-26 한국화학연구원 항암활성을 가지는 아크리딘 유도체
US20050222123A1 (en) 2004-01-27 2005-10-06 North Shore-Long Island Jewish Research Institute Cholinesterase inhibitors for treating inflammation
WO2006004201A1 (ja) * 2004-07-01 2006-01-12 Eisai R & D Management Co., Ltd. 神経再生促進剤
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AU2015205995A1 (en) * 2014-01-15 2016-07-28 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
KR101586473B1 (ko) * 2014-04-30 2016-01-19 (주)이컴프 스크롤 압축기
RU2567388C1 (ru) * 2014-12-10 2015-11-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Способ получения 9-бутиламино-3,3-диметил-3,4-дигидроакридин-1(2н)-она гидрохлорида

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE532397C (de) * 1929-04-23 1931-08-27 J D Riedel E De Haeen Akt Ges Verfahren zur Darstellung polycyclischer Basen
US3122553A (en) * 1959-08-20 1964-02-25 Bansen Inc 4-alkyl resorcinolates of aminoacridines
US3033866A (en) * 1960-02-17 1962-05-08 Smith Kline French Lab Novel 9-acridanemethanol derivatives
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US3318896A (en) * 1963-12-05 1967-05-09 Squibb & Sons Inc Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
DE2337474C2 (de) * 1973-07-24 1982-01-21 Hoechst Ag, 6000 Frankfurt Chemotherapeutisch wirksame Tetrahydroacridone, Verfahren zu ihrer Herstellung und sie enthaltende Mittel
PL101032B1 (pl) * 1976-04-06 1978-11-30 Sposob otrzymywania 1-nitro-9-dwualkilo-aminoizoalkiloamiroakrydyn lub ich soli
DE2748333A1 (de) * 1977-10-28 1979-05-03 Hoechst Ag Mittel gegen malaria
US4550113A (en) * 1982-08-19 1985-10-29 Nauchno-Issledovatelsky Institut Po Biologicheskikm Ispytaniyam Khimicheskikh Soedineny 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
DK569087A (da) * 1986-10-31 1988-05-01 Sumitomo Pharma Quinolin-derivater, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
DK167250B1 (da) 1993-09-27
AU615768B2 (en) 1991-10-10
JPH0584306B2 (ko) 1993-12-01
GR852555B (ko) 1986-02-24
AU3823489A (en) 1989-10-26
FI854156A0 (fi) 1985-10-23
AU4903885A (en) 1986-05-01
NZ213932A (en) 1990-12-21
CA1292744C (en) 1991-12-03
FI86421B (fi) 1992-05-15
HUT41009A (en) 1987-03-30
PT81362B (pt) 1987-11-30
US4839364A (en) 1989-06-13
EP0179383B1 (en) 1991-05-29
NZ229248A (en) 1990-12-21
DK168704B1 (da) 1994-05-24
FI86421C (fi) 1992-08-25
IE852632L (en) 1986-04-25
DK141992A (da) 1992-11-26
ES8701165A1 (es) 1986-11-16
ES8802383A1 (es) 1988-05-16
NO172847C (no) 1993-09-15
DK488885D0 (da) 1985-10-24
NO904711L (no) 1986-04-28
IL76796A (en) 1990-03-19
ES8801213A1 (es) 1988-01-01
JPH01125362A (ja) 1989-05-17
KR900007624B1 (ko) 1990-10-17
PT81362A (en) 1985-11-01
IL90300A (en) 1990-11-29
IE58696B1 (en) 1993-11-03
HU196183B (en) 1988-10-28
DK141992D0 (da) 1992-11-26
AU589141B2 (en) 1989-10-05
ES554569A0 (es) 1988-01-01
ATE63903T1 (de) 1991-06-15
ES554568A0 (es) 1988-05-16
EP0179383A2 (en) 1986-04-30
NO904711D0 (no) 1990-10-30
IL76796A0 (en) 1986-02-28
PH22614A (en) 1988-10-17
IL90300A0 (en) 1989-12-15
NO172847B (no) 1993-06-07
AR247394A1 (es) 1994-12-29
DE3582995D1 (de) 1991-07-04
ES548137A0 (es) 1986-11-16
EP0179383A3 (en) 1987-01-28
FI854156L (fi) 1986-04-26
DK488885A (da) 1986-04-26

Similar Documents

Publication Publication Date Title
KR860003227A (ko) 9-아미노-1,2,3,4,-테트라하이드로아크리딘-1-올의 제조방법
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
KR880001647A (ko) 티아졸리딘디온 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
KR850001746A (ko) 퀴나졸린 화합물의 제조방법
KR860001064A (ko) β-락탐 화합물의 제조방법
KR860003239A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR840001152A (ko) 신규 복소환(複素環) 화합물의 제법
KR840001974A (ko) 1-[3-(6-플루오로-1,2-벤즈이속사졸-3-일)프로필]-4-(치환된)-피페라진 및-피레리딘의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR860002517A (ko) 트리스(β,β-디메틸펜에틸) 주석 화합물의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR840004103A (ko) 디아졸릴 알칸올의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
KR830004322A (ko) 항알러지 및 항궤양제 1-옥소-1H-티아졸로 [3,2-a]피리미딘-2-카복사미드와 그의 중간물질
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR890002013A (ko) 치환된 피리딜알킬 케톤의 제조방법
KR830005225A (ko) 데오필린의 피페라진 유도체의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR850008163A (ko) 2,4-디아미노-6-할로게노-5-알킬티오-피리미딘의 제조방법
KR860002451A (ko) 아미드 화합물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20021011

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee